|
Name of the product: C3CO
Active ingredient: Bicalutamide 50 mg
Dosage form: film-coated tablets
Dispensing requirements: Rx only
Argentine Industry
Composition:
Each film-coated tablet contains bicalutamide 50 mg, lactose, sodium starch glycolate, polyvidone, magnesium stearate, titanium dioxide, hydroxypropyl methylcellulose, and polyethylene glycol 300.
Indications:
C3CO is indicated for the treatment of the metastasic prostate carcinoma (stage D2) in combination with LHRH analogue therapy.
Therapeutic action:
Antiandrogenic.
Storage:
Keep at temperature between 15º and 30º C, in the marketed packing.
Marketed presentations:
Packs containing 28 film-coated tablets.
Medicinal speciality authorised by the Ministry of Health.
Certificate Nº 49054
Laboratorio DOSA S.A.
Girardot 1369, (C1427AKC) Buenos Aires, Argentine
Pharmaceutical Director: María C. Terzo, Pharmacist
|
; EffectiveNewWin.focus(); "c3co")